𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancer

✍ Scribed by Yoshihiko Segawa; Katsuyuki Hotta; Shigeki Umemura; Yoshiro Fujiwara; Tetsu Shinkai; Hiroshi Ueoka; Nagio Takigawa; Masahiro Tabata; Katsuyuki Kiura; Mitsune Tanimoto

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
115 KB
Volume
107
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognostic model to predict outcomes in
Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment
✍ Min Jae Park; Jeeyun Lee; Jung Yong Hong; Moon Ki Choi; Joon Ho Yi; Su Jin Lee; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 437 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: A prognostic model based on clinical parameters for nonsmall cell lung cancer (NSCLC) patients treated with gefitinib (250 mg/day) as a salvage therapy was devised. ## METHODS: Clinical data regarding a total of 316 metastatic or recurrent NSCLC patients who were treat

Comparative analysis of epidermal growth
Comparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer
✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi

Epidermal growth factor receptor mutatio
Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer
✍ Jin-Yuan Shih; Chien-Hung Gow; Chong-Jen Yu; Chih-Hsin Yang; Yih-Leong Chang; Me πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 161 KB πŸ‘ 2 views

## Abstract Recently, mutations in the __epidermal growth factor receptor__ (__EGFR__) gene in nonsmall cell lung cancer (NSCLC) patients were reported to correlate with gefitinib response. Less than 30% of NSCLC patients are surgically resectable; however, molecular analysis has to rely on nonsurg